O-689
O-606 is a chemical compound that has been studied for its potential effects on the endocannabinoid system. It is a synthetic analog of the naturally occurring endocannabinoid anandamide, and it has been used in scientific research to explore the pharmacological properties of cannabinoid receptor agonists.
Chemical Structure and Properties[edit | edit source]
O-606 is a derivative of anandamide, which is an endogenous ligand for the cannabinoid receptors in the brain. The chemical structure of O-606 includes modifications that enhance its stability and affinity for the cannabinoid receptors, particularly CB1 and CB2 receptors. These modifications make O-606 a useful tool in the study of cannabinoid receptor function and the physiological roles of the endocannabinoid system.
Pharmacology[edit | edit source]
O-606 acts as a potent agonist at both CB1 and CB2 receptors. Its activity at these receptors has been shown to mimic the effects of anandamide, leading to various physiological and behavioral effects. Studies have demonstrated that O-606 can influence pain perception, appetite, mood, and memory, similar to other cannabinoids.
Mechanism of Action[edit | edit source]
The mechanism of action of O-606 involves binding to the CB1 and CB2 receptors, which are G-protein coupled receptors. Upon binding, O-606 activates these receptors, leading to a cascade of intracellular events that modulate neurotransmitter release and neuronal excitability. This activation can result in analgesic, anti-inflammatory, and neuroprotective effects.
Research Applications[edit | edit source]
O-606 has been used extensively in preclinical research to investigate the role of the endocannabinoid system in various physiological and pathological processes. It has been employed in studies examining the potential therapeutic applications of cannabinoid receptor agonists in conditions such as chronic pain, neurodegenerative diseases, and mood disorders.
Safety and Toxicology[edit | edit source]
As with many research chemicals, the safety profile of O-606 is not fully established. However, studies in animal models have provided some insights into its potential toxicological effects. It is important for researchers to handle O-606 with care and to follow appropriate safety protocols when conducting experiments.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD